We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDLS icon
11001
CALL
Noodles & Co
NDLS
$107M
$133K ﹤0.01%
3,550
-7,875
-69% -$350K
SMWB icon
11002
CALL
Similarweb
SMWB
$779M
$133K ﹤0.01%
16,100
-200
-1% -$2.11K
SVIX icon
11003
CALL
-1x Short VIX Futures ETF
SVIX
$173M
$133K ﹤0.01%
+12,800
New +$147K
PVLA
11004
CALL
Palvella Therapeutics
PVLA
$2.25B
$133K ﹤0.01%
886
-53
-6% -$9.67K
LFTRU
11005
DELISTED
Lefteris Acquisition Corp. Unit
LFTRU
$133K ﹤0.01%
13,442
-101
-0.7% -$1K
CYCN icon
11006
CALL
Cyclerion Therapeutics
CYCN
$17.7M
$132K ﹤0.01%
12,025
+4,875
+68% +$69.8K
ENTX icon
11007
CALL
Entera Bio
ENTX
$500M
$132K ﹤0.01%
99,300
-1,500
-1% -$3.33K
FOSL icon
11008
CALL
Fossil Group
FOSL
$329M
$132K ﹤0.01%
25,600
-19,400
-43% -$157K
VIP
11009
CALL
Vulcan Infrastructure and Power
VIP
$33.4M
$132K ﹤0.01%
5,202
+1,641
+46% +$92.3K
LFST icon
11010
PUT
Lifestance Health
LFST
$4.75B
$132K ﹤0.01%
23,800
+10,300
+76% +$78.9K
LGMK
11011
DELISTED
LogicMark
LGMK
$132K ﹤0.01%
242
+192
+384% +$143K
NXTC icon
11012
PUT
NextCure
NXTC
$37.6M
$132K ﹤0.01%
+2,333
New +$122K
SEER icon
11013
CALL
Seer Inc
SEER
$115M
$132K ﹤0.01%
14,700
-18,700
-56% -$171K
SKYT
11014
PUT
DELISTED
SkyWater Technology
SKYT
$132K ﹤0.01%
21,900
-25,100
-53% -$172K
OMIC
11015
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$132K ﹤0.01%
1,152
-13,798
-92% -$1.62M
TINV.U
11016
DELISTED
Tiga Acquisition Corp. Units, each consisting of one Class A ordinary share and one half of one warrant
TINV.U
$132K ﹤0.01%
12,506
-378
-3% -$4.01K
ASPS icon
11017
PUT
Altisource Portfolio Solutions
ASPS
$64.4M
$131K ﹤0.01%
+1,525
New +$133K
CCC
11018
CCC Intelligent Solutions
CCC
$4.11B
$131K ﹤0.01%
+14,220
New +$131K
LASR icon
11019
PUT
nLIGHT
LASR
$3.03B
$131K ﹤0.01%
12,800
-41,800
-77% -$540K
PLUR icon
11020
Pluri
PLUR
$17.3M
$131K ﹤0.01%
13,359
+5,998
+81% +$73.8K
ROVR
11021
CALL
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$131K ﹤0.01%
34,800
-12,000
-26% -$61.8K
LHC.U
11022
DELISTED
Leo Holdings Corp. II Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant
LHC.U
$131K ﹤0.01%
13,264
+975
+8% +$9.62K
TGA
11023
PUT
DELISTED
Transglobe Energy Corp
TGA
$131K ﹤0.01%
+38,700
New +$166K
ABSI icon
11024
PUT
Absci
ABSI
$1.58B
$130K ﹤0.01%
39,100
+7,100
+22% +$35.3K
ACCO icon
11025
CALL
Acco Brands
ACCO
$401M
$130K ﹤0.01%
19,900
+5,300
+36% +$38.6K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.